Publication:
Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles

dc.contributor.authorFlorian Fögeren_US
dc.contributor.authorWilai Noonpakdeeen_US
dc.contributor.authorBrigitta Loretzen_US
dc.contributor.authorSongwut Joojuntren_US
dc.contributor.authorWilli Salvenmoseren_US
dc.contributor.authorMarlene Thaleren_US
dc.contributor.authorAndreas Bernkop-Schnürchen_US
dc.contributor.otherMedizinische Universitat Innsbrucken_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-08-20T07:24:11Z
dc.date.available2018-08-20T07:24:11Z
dc.date.issued2006-08-17en_US
dc.description.abstractNew effective antimalarial agents are urgently needed due to increasing drug resistance of Plasmodium falciparum. Phosphorothioate antisense oligodeoxynucleotides (ODNs) silencing of malarial topoisomerase II gene have shown to possess promising features as anti malarial agents. In order to improve stability and to increase intracellular penetration, ODNs were complexed with the biodegradable polymer chitosan to form solid nanoparticles with an initial diameter of ∼55 nm. The particle zetapotential depended on the chitosan/ODN mass ratio. Nanoparticles with mass ratio of 2:1 displayed a positive surface charge (+15 mV) whereas particles with 1:1 mass ratio were negatively charged (-20 mV). Additionally nanoparticles were found to protect ODNs from nuclease degradation. P. falciparum K1 strain was exposed to the chitosan/ODN-nanoparticles for 48 h in order to examine the effects of chitosan/antisense (AS) and chitosan/sense (S) oligodeoxynucleotide nanoparticles on malaria parasite growth. Both negatively and positively charged antisense nanoparticles as well as free antisense ODNs (in a final concentration of 0.5 μM) showed sequence specific inhibition compared with sense sequence controls. However, nanoparticles were much more sequence specific in their antisense effect than free ODNs. Nanoparticles with negative surface charge exhibited a significantly stronger inhibitory effect (∼87% inhibition) on the parasite growth in comparison to the positive ones (∼74% inhibition) or free ODNs (∼68% inhibition). This is the first study demonstrating the susceptibility of P. falciparum to antisense nanoparticles. © 2006 Elsevier B.V. All rights reserved.en_US
dc.identifier.citationInternational Journal of Pharmaceutics. Vol.319, No.1-2 (2006), 139-146en_US
dc.identifier.doi10.1016/j.ijpharm.2006.03.034en_US
dc.identifier.issn03785173en_US
dc.identifier.other2-s2.0-33745875927en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/23900
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33745875927&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleInhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticlesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33745875927&origin=inwarden_US

Files

Collections